The National Health Insurance Bureau has started to subsidize a drug which can successfully help prevent the onset of diabetes, strokes, heart failure and cardiovascular disorders, cardiologists said.
According to Norman Sharpe of the University of Auckland's cardiology department, studies performed on 9,500 patients over the age of 55 indicated that, in individuals with high blood pressure, the drug Ramipril can decrease their chances of suffering a stroke by 32 percent, heart failure by 20 percent and death from cardiovascular disorders by 26 percent.
Chiang Chern-en (江晨恩), a cardiologist at the Taipei Veterans General Hospital, said Ramipril is the only medication approved by the US Food and Drug Administration (FDA) to prevent, not merely treat, cardiovascular disorders.
National Health Insurance coverage will impose no age limits, although the experimental subjects were all over the age of 55.
Tests showed the medication can help prevent the onset of diabetes in patients with high blood pressure, decreasing the chance of developing diabetes by 34 percent. In a group of 5,887 patients, half were given a 10mg dosage of Ramipril daily. In the group that received Ramipril, 102 patients were later diagnosed with diabetes, compared to the 155 patients who had been given a placebo.
According to Chiang, diabetes is becoming a problem in Taiwan, with the number of diabetics increasing at a rate of 9.1 percent each year.
Patients with high blood pressure, a high index of bad cholesterol, abdominal obesity and insulin resistance are likely to develop diabetes, Chiang said.
He said that Ramipril could be used to treat high blood pressure and prevent the future onset of diabetes. It can also slow the process of kidney failure brought on by diabetes.
Chiang conducted his own experiments to determine if the medication was appropriate for Tai-wanese patients, who generally use lower dosages. A group of 275 patients, whose average age was 69, began with a 2.5mg dosage, which was gradually increased to 10mg, the amount used in previous tests.
Chiang stated that for 96.4 percent of the patients, 10mg was an appropriate dosage, effective in decreasing the average blood pressure from 149/83mmHg to 139/80mmHg in three months.
He said that 265 of the patients are still taking the medication.
Chiang said the primary side-effect observed was coughing.
The medication should not be taken during pregnancy, he said.
Taiwan is stepping up plans to create self-sufficient supply chains for combat drones and increase foreign orders from the US to counter China’s numerical superiority, a defense official said on Saturday. Commenting on condition of anonymity, the official said the nation’s armed forces are in agreement with US Admiral Samuel Paparo’s assessment that Taiwan’s military must be prepared to turn the nation’s waters into a “hellscape” for the Chinese People’s Liberation Army (PLA). Paparo, the commander of the US Indo-Pacific Command, reiterated the concept during a Congressional hearing in Washington on Wednesday. He first coined the term in a security conference last
Prosecutors today declined to say who was questioned regarding alleged forgery on petitions to recall Democratic Progressive Party (DPP) legislators, after Chinese-language media earlier reported that members of the Chinese Nationalist Party (KMT) Youth League were brought in for questioning. The Ministry of Justice Investigation Bureau confirmed that two people had been questioned, but did not disclose any further information about the ongoing investigation. KMT Youth League members Lee Hsiao-liang (李孝亮) and Liu Szu-yin (劉思吟) — who are leading the effort to recall DPP caucus chief executive Rosalia Wu (吳思瑤) and Legislator Wu Pei-yi (吳沛憶) — both posted on Facebook saying: “I
The Ministry of Economic Affairs has fined Taobao NT$1.2 million (US$36,912) for advertisements that exceed its approved business scope, requiring the Chinese e-commerce platform to make corrections in the first half of this year or its license may be revoked. Lawmakers have called for stricter enforcement of Chinese e-commerce platforms and measures to prevent China from laundering its goods through Taiwan in response to US President Donald Trump’s heavy tariffs on China. The Legislative Yuan’s Finance Committee met today to discuss policies to prevent China from dumping goods in Taiwan, inviting government agencies to report. Democratic Progressive Party Legislator Kuo Kuo-wen (郭國文) said
The Ministry of Economic Affairs has fined Taobao NT$1.2 million (US$36,900) for advertisements that exceeded its approved business scope and ordered the Chinese e-commerce platform to make corrections in the first half of this year or its license would be revoked. Lawmakers have called for stricter supervision of Chinese e-commerce platforms and more stringent measures to prevent China from laundering its goods through Taiwan as US President Donald Trump’s administration cracks down on origin laundering. The legislature’s Finance Committee yesterday met to discuss policies to prevent China from dumping goods in Taiwan, inviting government agencies to report on the matter. Democratic Progressive Party